Bioxcel Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Bioxcel Therapeutics (BTAI) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Bioxcel Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Bioxcel Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Bioxcel Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-06-30 | $63 | 45 | 1.40 |
| 2026-03-31 | $54 | 45 | 1.20 |
| 2025-09-30 | $115 | 45 | 2.56 |
| 2025-03-31 | $234 | 116 | 2.02 |